Best ASCO Journals Podcasts (2024)

1
iwCAR-T sessions: Advances in breast and gynecological cancers 23:34

2h ago23:34

23:34

In this week’s episode, we join Jennifer Specht from Fred Hutchinson Cancer Center, Saurabh Garg from Moffitt Cancer Center, and Rizwan Romee from Dana-Farber Cancer Institute on pioneering advancements in CAR-T cell therapies for breast and gynecological cancers, as discussed at the recent 6th annual iwCAR-T workshop in Miami, Florida. Tune in to …

1
314: JD Vance's biotech ties, Cassava resignations, and insulin shortages 33:02

1h ago33:02

33:02

Our Washington correspondent Sarah Owermohle joins us to talk about how JD Vance, Donald Trump's newly announced running mate, could influence health policy if Trump wins the election. We also discuss the latest news in the biopharma industry, including the latest developments in the ongoing controversy surrounding Cassava’s Alzheimer’s drug, short…

1
S1 Ep118: Overcoming Physical and Social Barriers in the Lymphoma Field 19:14

1h ago19:14

19:14

As part of the Breaking Barriers: Women in Oncology program, CancerNetwork® spoke with Julie M. Vose, MD, MBA, and Avyakta Kallam, MD, about the evolution of their careers in the hematology-oncology space, including some of the critical advances and challenges associated with their work in the lymphoma field. Vose is division chief, Neumann M. and …

1
Novel developments in lower-risk MDS & important practical considerations when treating patients 51:42

2h ago51:42

51:42

In today’s VJHemOnc podcast, we will be sharing novel developments in lower-risk myelodysplastic syndromes (LR-MDS) and important practical considerations when treating patients. You will hear from experts Amer Zeidan, MBBS, Yale University and Yale Cancer Center, New Haven, CT, Rena Buckstein, MD, FRCPC, Odette Cancer Research Program, Sunnybrook …

1
iwCAR-T sessions: clinical advances in lung cancer 14:15

1d ago14:15

14:15

Welcome to another episode of VJOncology! In this episode, we dive into cutting-edge CAR-T cell therapies for the management of lung cancers, discussed at the sixth International Workshop on CAR-T in Miami, Florida. Join Julian Molina from the Mayo Clinic, Ben Creelan from Moffitt Cancer Center, and Adam Schoenfeld from Memorial Sloan Kettering Can…

1
Clinical Highlights From ASCO 2024 17:33

24h ago17:33

17:33

Nora Disis, MD, editor in chief of JAMA Oncology and a JAMA deputy editor, and guests share JAMA Network highlights from the American Society of Clinical Oncology’s annual meeting, including new research on colorectal cancer screening, an antibody therapy for non–small cell lung cancer, access to oncology clinical trials, and a new model of palliat…

1
313: Biotech layoffs, founder-focused VC, & a big pharma exit 34:52

2d ago34:52

34:52

STAT's West Coast biotech reporter Jonathan Wosen joins "The Readout LOUD" to discuss what’s driving workforce cuts. Plus, entrepreneurs Alexis Borisy and Zach Weinberg call in to discuss their biotech incubator Curie.Bio and how they hope to “free the founders.” We also discuss a big change in Pfizer’s leadership and the debate over a new side eff…

1
Functional Disability Among US Cancer Survivors 16:12

2d ago16:12

16:12

Dr. Shannon Westin and her guest, Dr. Chao Cao, discuss the paper "Prevalence and Cancer-Specific Patterns of Functional Disability Among US Cancer Survivors, 2017-2022" recently published in the JCO. TRANSCRIPT The guest on this podcast episode has no disclosures to declare. Dr. Shannon Westin: Hello, everyone, and welcome to another episode of JC…

1
Updates on the use of BCMA-targeting bispecific antibodies in R/R multiple myeloma: insights from EHA & ASCO 2024 16:18

5d ago16:18

16:18

BCMA-targeting bispecific antibodies treat multiple myeloma by binding to BCMA on malignant plasma cells and directing T-cells to initiate targeted cell killing. This podcast provides updates on the use of BCMA-targeting bispecific antibodies in relapsed/refractory (R/R) multiple myeloma from the 2024 American Society of Clinical Oncology (ASCO) Me…

1
S1 Ep117: Epcoritamab Approval Expands Bispecific Use in Follicular Lymphoma 13:01

10d ago13:01

13:01

Tycel Phillips, MD, spoke with CancerNetwork® ahead of the FDA’s accelerated approval of epcoritamab-bysp (Epkinly) for patients with relapsed/refractory follicular lymphoma to discuss how this agent may impact the treatment paradigm. Phillips, an associate professor in the Division of Lymphoma and Department of Hematology & Hematopoietic Stem Cell…

1
The Future of Wearables and Mobile Devices for Patient Care 30:34

8d ago30:34

30:34

Can data from wearable devices and electronic health records enhance quality improvement in health care? In this Q&A, Sachin Kheterpal, MD, MBA, the University of Michigan Medical School Associate Dean for Research Information Technology, joins JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss the potential of data from mobile …

1
Highlights in colorectal cancer at ASCO and ESMO GI 2024 9:42

8d ago9:42

9:42

In this week’s podcast, we will discuss the most recent developments in colorectal cancer from the 2024 ASCO and ESMO Gastrointestinal (GI) Annual Meetings held in Chicago, IL and Munich, Germany respectively. Join us as five renowned experts discuss highly anticipated findings from clinical trials across different colorectal cancer subtypes. Heinz…

1
S1 Ep116: Leveraging Artificial Intelligence Evolutions in Prostate Cancer Care 31:49

12d ago31:49

31:49

In a conversation with CancerNetwork®, James B. Yu, MD, MHS, FASTRO, and Julian C. Hong, MD, MS, spoke about their study titled AI Use in Prostate Cancer: Potential Improvements in Treatments and Patient Care, which was published in the May issue of the journal ONCOLOGY®. Yu is a radiation oncologist in the Department of Radiation Oncology at Smilo…

1
Updates in the treatment of CLL from EHA 2024: BTK and BCL2 inhibitor combinations, BTK degraders, and more 12:10

12d ago12:10

12:10

In today's VJHemOnc podcast, we will be sharing key updates in the treatment of chronic lymphocytic leukemia (CLL) and Richter’s transformation (RT) from the 29th Congress of the European Hematology Association (EHA) in Madrid, Spain. You will hear from experts Toby Eyre, MBChB (Hons), DipMedEd, MRCP (UK), FRCPath (UK), MD, Oxford University Hospit…

1
June 2024 Medical News Summary 13:53

15d ago13:53

13:53

Multiple Factors Have Contributed to the Comeback of Syphilis in the US; How Statin Eligibility Could Change With the New CVD Risk Calculator Related Content: Syphilis Has Surged for Reasons That Go Beyond the Pathogen That Causes It New Cardiovascular Disease Risk Calculator Could Eliminate the Need for Statins for Millions…

1
What a Neurologist With Alzheimer Disease Wants People to Know 16:29

15d ago16:29

16:29

Daniel Gibbs, MD, received an Alzheimer disease diagnosis 8 years ago, and in hindsight, believes the earliest symptoms appeared years before that. In this podcast, the retired neurologist speaks with JAMA Medical News lead senior staff writer Rita Rubin, MA, about how even with the neurodegenerative condition, it’s still possible to enjoy a life w…

1
“People Are Claiming That Radiation Is Dead”: Esophagus Cancer at ASCO24 With Krish and Nina 51:28

16d ago51:28

51:28

The Accelerators (Drs. Matt Spraker and Simul Parikh) host Radiation Oncologists and elite GI educators Drs. Krish Jethwa and Nina Sanford. We discuss the exciting phase III ESOPEC study presented at ASCO 2024. The study demonstrated an overall survival benefit for perioperative FLOT chemotherapy versus pre-operative chemoradiation therapy for GE j…

1
The OJC Episode 7: ASCO 2024 Special Part 2 51:05

16d ago51:05

51:05

Send us a Text Message. Discover the latest breakthroughs from ASCO 2024 with The Oncology Journal Club team! Professor Chris Jackson, who, despite battling the infamous man flu, brings his A-game to dissect the NADINA study. Learn how neoadjuvant ipilimumab and nivolumab are transforming resectable stage 3 melanoma treatment with a remarkable 26 p…

1
312: Medicare coverage for GLP-1 drugs, AI, and health care at the presidential debate 28:33

16d ago28:33

28:33

STAT health tech reporter Brittany Trang guest co-hosts "The Readout LOUD" this week, where we discuss AI for drug development, the latest in the H5N1 bird flu outbreak, a surprise entrant to the GLP-1 field, and more news in the life sciences. And STAT chief Washington correspondent Rachel Cohrs Zhang joins the podcast to talk about a new proposal…

1
Highlights from ISA 2024: the importance of early diagnosis in AL amyloidosis, trials in progress & patient selection for SCT 8:43

18d ago8:43

8:43

Welcome to today's VJHemOnc podcast episode, where we will be sharing key highlights from the 2024 International Symposium on Amyloidosis (ISA), which was held in Rochester, MN. This podcast covers a variety of unmet needs in light chain (AL) amyloidosis, as well as emerging trials in the field. Join leading experts Mario Nuvolone, MD, PhD, Univers…

1
CAR T-Cell Therapy for Richter’s Transformation 9:19

19d ago9:19

9:19

In this JCO Article Insights episode, Alexandra Rojek provides a summary on "Anti-CD19 Chimeric Antigen Receptor T-cell therapy for Richter’s Transformation: An International, Multicenter, Retrospective Study by Kittai, et al published in the Journal of Clinical Oncology March 29th, 2024. TRANSCRIPT The guest on this podcast episode has no disclosu…

1
S1 Ep115: Ensuring Quality Outcomes in Hematologic Cancer Subgroups at EHA 2024 8:13

20d ago8:13

8:13

At the 2024 European Hematology Association (EHA) Congress, CancerNetwork® spoke with a variety of experts in the hematologic oncology space about optimizing outcomes across different patient populations and subgroups based on updated research they presented at the meeting. Manali Kamdar, MD, an associate professor of medicine-hematology and clinic…

1
Skin Cancer Highlights at ASCO 2024 19:16

20d ago19:16

19:16

Welcome to another episode of VJ Oncology Podcasts! Today, we spotlight key advances in skin cancer research shared at ASCO 2024. Join us as six leading experts reveal groundbreaking findings from recent clinical trials. First, Georgina Long from the University of Sydney discusses the NADINA trial, a landmark Phase III study on neoadjuvant immunoth…

1
The OJC Episode 6: ASCO 2024 Special Part 1 43:59

26d ago43:59

43:59

Send us a Text Message. Imagine having the latest breakthroughs in oncology from the ASCO 2024 conference delivered with humour, expert insight and personal stories. That's exactly what you'll get in this special episode of the Oncology Journal Club, where Professor Craig Underhill, Dr. Kate Clark, and Professor Christopher Jackson dissect the most…

1
311: Fauci's memoir, Alnylam's tenuous trial, and a mid-year review 34:10

25d ago34:10

34:10

STAT reporter Jason Mast joins us to discuss Anthony Fauci's memoir "On Call," which was published this week. Hosts Allison DeAngelis and Adam Feuerstein also dissect Alnylam's forthcoming clinical trial data and take stock of how the biotech markets are succeeding and potentially falling flat midway through the year. For more on Fauci's memoir "On…

1
S1 Ep114: Applying Updated Breast Cancer Findings From ASCO to Clinical Practice 31:19

27d ago31:19

31:19

Following the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, Neil M. Iyengar, MD, and Paolo Tarantino, MD, co-hosted a live X Space with CancerNetwork® and discussed the latest trial updates that may impact clinical practice in the breast cancer field. Iyengar is an associate attending physician at Memorial Sloan Kettering Cancer…

1
310: Duchenne gene therapy setback, Alzheimer's drug endorsement & why a STAT reporter buys weed (for journalism) 38:46

30d ago38:46

38:46

STAT's Nicholas Florko joins to explain what it means to be a reporter writing about the commercial determinants of health. Hint: Florko's most recent stories focus on weed, vapes, and raw milk. And instead of being chained to a desk, he often drives around to convenience stores and buy bad stuff — all in the name of good journalism. But first, co-…

1
On Advocacy and Revolutions: In Conversation with Matthew Zachary 44:17

1M ago44:17

44:17

Send us a Text Message. Welcome to the latest episode of Supportive Care Matters. Join Medical Oncologist Professor Bogda Koczwara AM and advocate Matthew Zachary, founder of Stupid Cancer and the creative force behind the documentary "Cancer Mavericks." Matthew shares the profound journeys of pioneers who transformed cancer survivorship from the 1…

1
Treating LR-MDS beyond ESA failure: currently approved agents, novel approaches & future outlooks 46:31

1M ago46:31

46:31

While there have been advances in the treatment of lower-risk myelodysplastic syndromes (LR-MDS) in recent years, one major challenge that remains is the treatment of patients following the failure of erythropoiesis-stimulating agents (ESAs). In this podcast, experts Amer Zeidan, MBBS, Yale Cancer Center, New Haven, CT, Valeria Santini, MD, Univers…

1
S1 Ep113: Optimizing Metastatic CRC Outcomes Following Fruquintinib Approval 13:43

1M ago13:43

13:43

In a conversation with CancerNetwork®, Jagoda Misniakiewicz, PharmD, a clinical pharmacy specialist in the Clinical Pharmacy and Outcomes Sciences Department at Hollings Cancer Center of the Medical University of South Carolina, spoke about the use of fruquintinib (Fruzaqla) as a treatment option for those with metastatic colorectal cancer (CRC). T…

1
iwCAR-T sessions: Clinical Advances in Head and Neck Cancer and Brain Tumors 7:14

1M ago7:14

7:14

Welcome to another episode of VJ Oncology! In this episode, we delve into pioneering CAR-T strategies for head and neck cancers and brain tumors, as discussed at the recent iwCAR-T workshop in Miami, Florida. Join Kedar Khartani from Moffitt Cancer Center and Susanna Baumeister from Dana-Farber Cancer Institute as they explore groundbreaking CAR-T …

1
309: Psychedelics at the FDA, ASCO recap, & MorphoSys update 29:34

1M ago29:34

29:34

STAT colleague Meghana Keshavan joins us to dissect Lykos Therapeutics' meeting with an FDA advisory committee. We also discuss the latest news in the health and life sciences, including stories from major biotech conferences. To learn more about Lykos' advisory committee meeting, go here; for more on the tumult at BIO, go here; for a recap of ASCO…

1
Episode 5: Prostate Cancer Treatment + Alcohol + Adjuvant Pembro + Quick Bites 36:55

1M ago36:55

36:55

Send us a Text Message. Join us on this episode of The Oncology Journal Club Podcast as we dissect the latest research that point to new standards of care. Join our esteemed Hosts, Professor Craig Underhill, Dr. Kate Clarke and Professor Christopher Jackson for the low down on the latest oncology papers. Craig looks at how three-agent regimens have…

1
“Were Not the Only People in Town”: Introducing Cameron Tharp, M.P.H., R.T.T. 32:37

1M ago32:37

32:37

The Accelerators (Drs. Matt Spraker and Simul Parikh) host a very special guest! Cameron Tharp, M.P.H., R.T.T. has joined the TAP team to help us out with show development and offer new perspective to our content. We introduce Cameron and tease future discussions on a hot radiation therapy topic: Advanced Practice Radiation Therapy. Of course, Simu…

1
EAZ171: Predictors of TIPN in Black Women with Breast Cancer 14:38

1M ago14:38

14:38

Dr. Shannon Westin and her guest, Dr. Bryan Schneider discuss the article “ECOG-ACRIN EAZ171: Prospective Validation Trial of Germline Predictors of Taxane-induced Peripheral Neuropathy in Black Women with Early Stage Breast Cancer” recently published in the JCO and presented at the 2024 ASCO Annual Meeting. TRANSCRIPT The guest on this podcast epi…

1
S1 Ep112: Optimizing NSCLC Outcomes Via Technological Advances in Radiation Oncology 26:47

2M ago26:47

26:47

In a conversation with CancerNetwork®, Terence T. Sio, MD, MS, discussed how technological advancements in radiation oncology have impacted the modern treatment landscape for patients with non–small cell lung cancer (NSCLC). Sio, a professor of radiation oncology at Mayo Clinic in Phoenix, Arizona, first outlined the use of immunotherapy and other …

1
BPDCN treatment and management: CD123-targeting agents, CNS involvement & approaching pediatric/AYA patients 34:39

1M ago34:39

34:39

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive hematologic malignancy originating from plasmacytoid dendritic cells, characterized by skin lesions and frequent involvement of bone marrow and lymphoid tissues. Patients have a poor prognosis, making early diagnosis and advanced treatments, including targeted therapies, crucial …

1
May 2024 Medical News Summary 15:31

2M ago15:31

15:31

College Athlete Deaths by Suicide Have Doubled; Why the Bird Flu Outbreak in Dairy Cows Matters; Combined COVID-19 and Flu Vaccines Could Be Available Next Year Related Content: College Athlete Deaths by Suicide Have Doubled, and Researchers Want to Know Why Bird Flu Outbreak in Dairy Cows Is Widespread, Raising Public Health Concerns Combined Vacc…

1
308: An ASCO preview & another Duchenne trial failure 28:34

2M ago28:34

28:34

We preview some of the research that will be presented at The American Society of Clinical Oncology conference in Chicago. We also discuss the latest news in the health and life sciences, including a milestone in lung disease R&D and a Duchenne muscular dystrophy confirmatory trial failure. To read more about Merus' combination therapy, go here; Fo…

1
S1 Ep111: Ensuring Quality Rectal Cancer Surgery at NAPRC-Accredited Institutions 21:37

2M ago21:37

21:37

Through elaborate multidisciplinary collaboration, institutions with National Accreditation Program for Rectal Cancer (NAPRC) standards can deliver a “high level of care” in the surgical treatment of patients with rectal cancer, according to Steven Wexner, MD, PhD, and Arielle Kanters, MD. In a conversation with CancerNetwork®, Wexner and Kanters d…

1
JCO Article Insights: Final Analysis of the Ro-CHOP Trial 8:49

2M ago8:49

8:49

In this JCO Article Insights episode, Alexandra Rojek provides a summary on "Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial" by Camus et al published Febr…

Podcasts Worth a Listen

ASCO Journals Podcasts

Podcasts Worth a Listen

Quick Reference Guide